Launch memo
- paper trading
- the first three years live
All three figures are Sharpe ratios: yearly return divided by yearly bumpiness.
The Incubator
Careful quants don't trust a backtest. They hold back data for a final test, then trade new strategies with paper money for a year before launch. Run that whole process here on 1,000 strategies. One of them has a real edge.
Launch memo
All three figures are Sharpe ratios: yearly return divided by yearly bumpiness.
Each gate is a good idea on its own. The trouble is what happens between them.
Holding back data works once. When too few strategies pass, the team tweaks them and checks the same held-back data again. Every look leaks a little of it into the search. This run looked times before it had enough winners. A strategy with no edge passes a single check about of the time.
A year of results is very noisy. A strategy with a real Sharpe ratio of 1 needs about years of results before a standard test says it is not luck. A Sharpe ratio of 0.5, more typical of real strategies, needs years.
Incubate several and launch the best, and you have run a new search, only slower. The best of many ghosts looks good by luck alone. Judging the best of them fairly takes even longer.
Years of results before the best of the strategies you incubated clears a 5 percent test, allowing for how many you incubated. This is the Bonferroni rule, which is mild.
The Sharpe ratio the luckiest of your incubated strategies should show when none of them has any edge, by years of paper trading.
Fund companies seed many funds in private and only open the winners to the public. The record you see is the one that survived.
Evans looked at mutual funds started this way. While incubated, they beat comparable funds by 3.5 percent a year. Once they opened to the public, the extra return was gone. Vanguard checked 637 indexes that ETFs were built on: 87 percent beat the market before the fund launched, 51 percent after. Banks' own sold strategies showed a median Sharpe ratio of 1.20 in the backtest and 0.31 live.
Before you trust a track record, ask: how many did you incubate, and how often did you look at the test data?